Clinical Trial Update: REGEND001 Autologous Basal Layer Stem Cell Transplantation for Interstitial Lung Disease (ILD): A Translational Application Study [Phase 1]

View source ↗

Summary

Phase 1 translational study evaluating autologous basal layer stem cell transplantation (REGEND001) for interstitial lung disease; the trial is not yet recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Interstitial Lung Disease

Drugs mentioned

• REGEND001

Snippet

Sponsor: Ruijin Hospital | Conditions: Interstitial Lung Disease (ILD) | Phase 1 | Status: NOT_YET_RECRUITING